---
title: "ARA-290 vs Thymosin alpha-1: vial sizes, prices, specs"
description: "ARA-290 vs Thymosin alpha-1: ARA-290 from £25.99 (2 sizes), Thymosin alpha-1 from £18.95 (2 sizes)."
canonical: https://www.sablepeptides.co.uk/versus/ara-290/thymosin-alpha-1
dateModified: 2026-11-09
publisher: Sable Peptides Limited (UK company 17488610)
note: Research use only. Not for human or veterinary use.
---

Comparison · not a ranking

# ARA-290 compared with Thymosin alpha-1

ARA-290 and Thymosin alpha-1 are separate catalogue items. They are not interchangeable.A CoA for every lot; each vial carries a printed lot number that matches it. Request yours and we email it within 2 hours. Research use only. Not a medicine.

Last verified 9 Nov 2026. UK prices checked daily.

ARA-290 and Thymosin alpha-1 are not the same material. ARA-290 is a 11-residue peptide, while Thymosin alpha-1 is a 28-residue peptide. ARA-290: C51H84N16O21, 1257.3 g/mol, CAS 1208243-50-8. Thymosin alpha-1: C129H215N33O55, 3108.3 g/mol, CAS 62304-98-7. By sequence, ARA-290 is pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser and Thymosin alpha-1 is Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN. In short, their molecular weights differ by about 1851.0 g/mol; their sequences differ in length (11 versus 28 residues). Each has its own reference record, which lists the source for every figure above. Sable Peptides, a UK supplier operating since 2019, lists both as lyophilised research material; every vial carries a lot number and a certificate of analysis exists for every lot — request yours at /coa-request and we email it within 2 hours. This intro compares identity only and ranks neither compound. Research use only. Not a medicine. Not for human or veterinary use.

Sources: [pubchem.ncbi.nlm.nih.gov](https://pubchem.ncbi.nlm.nih.gov/compound/16130571) · [pubchem.ncbi.nlm.nih.gov](https://pubchem.ncbi.nlm.nih.gov/compound/91810664)

[/ref/ara-290](https://www.sablepeptides.co.uk/ref/ara-290) · [/ref/thymosin-alpha-1](https://www.sablepeptides.co.uk/ref/thymosin-alpha-1)

ARA-290 and Thymosin alpha-1 are two records in the Sable Peptides catalogue at https://www.sablepeptides.co.uk/versus/ara-290/thymosin-alpha-1. These prices are both Sable catalogue prices. They are not a comparison with another shop. This page does not rank either compound. Each page shows the catalogue price. A market comparison appears only when an exact, current, approved listing for that size is on record. Only a row with the same amount is a like-for-like price.

Research use only. Not a medicine. Not for human or veterinary use. [Disclaimer](/disclaimer)

| Amount | ARA-290 | Thymosin alpha-1 |
| --- | --- | --- |
| 5 mg | £25.99 | £18.95 |

## Reference facts

| Fact | ARA-290 | Thymosin alpha-1 |
| --- | --- | --- |
| Molecular weight | 1257.3 g/mol | 3108.3 g/mol |
| Molecular formula | C51H84N16O21 | C129H215N33O55 |
| CAS number | 1208243-50-8 | 62304-98-7 |
| Compound class | peptide | peptide |

Sources: [pubchem.ncbi.nlm.nih.gov](https://pubchem.ncbi.nlm.nih.gov/compound/91810664), [pubchem.ncbi.nlm.nih.gov](https://pubchem.ncbi.nlm.nih.gov/compound/16130571) Verified 2026-11-09

Category

ARA-290Repair

Thymosin alpha-1Repair

Research use only

ARA-290Yes

Thymosin alpha-1Yes

Vials

ARA-2902

Thymosin alpha-12

Record

ARA-290ara-290

Thymosin alpha-1thymosin-alpha-1

[ARA-290](/ara-290-uk) · [Thymosin alpha-1](/thymosin-alpha-1-uk)

## Questions this page answers

How does ARA-290 compare with Thymosin alpha-1?

Same vial amounts are shown side by side with each catalogue price. Different amounts are not treated as the same price. No effect is compared, and another seller is not compared.

Which is better?

This page does not say. It does not rank safety, strength, or effect.

What is the lowest catalogue price per mg for ARA-290 and Thymosin alpha-1?

ARA-290: £2.19/mg on the 16 mg vial (£35.00). Thymosin alpha-1: £2.70/mg on the 10 mg vial (£27.00). Different compounds; this is a catalogue price fact, not a ranking.

How many vial sizes are listed for each?

ARA-290: 5 mg, 16 mg. Thymosin alpha-1: 5 mg, 10 mg.

## Both compounds

-   [ara 290 research vial](/product/ara-290-16mg)
-   [ara 290 reference data](/ref/ara-290)
-   [ara 290 research overview](/learn/ara-290)
-   [thymosin alpha 1 research vial](/product/thymosin-alpha-1-10mg)
-   [thymosin alpha 1 reference data](/ref/thymosin-alpha-1)
-   [thymosin alpha 1 research overview](/learn/thymosin-alpha-1)

## Related research

-   [Thymosin alpha-1 research brief](/learn/thymosin-alpha-1)
-   [ARA-290 research brief](/learn/ara-290)
-   [Thymosin alpha-1 reference data](/ref/thymosin-alpha-1)
-   [ARA-290 reference data](/ref/ara-290)
-   [Thymosin alpha-1](/thymosin-alpha-1-uk)

## In-depth comparison

*Sable research note. Updated 2026-10-10. Research use only.*

## Short answer

ARA-290 (cibinetide) and Thymosin alpha-1 (thymalfasin) are different compounds. ARA-290 (cibinetide) is an erythropoietin-derived linear peptide; Thymosin alpha-1 (thymalfasin) is a N-acetylated thymic peptide. By PubChem's computed values, Thymosin alpha-1 (thymalfasin) (3108.3 g/mol) is about 2.5 times the mass of ARA-290 (cibinetide) (1257.3 g/mol). Sable lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.

## At a glance

|  | ARA-290 (cibinetide) | Thymosin alpha-1 (thymalfasin) |
| --- | --- | --- |
| Class | erythropoietin-derived linear peptide | N-acetylated thymic peptide |
| Formula (PubChem) | C51H84N16O21 | C129H215N33O55 |
| Molecular weight (PubChem, g/mol) | 1257.3 | 3108.3 |
| PubChem CID | 91810664 | 16130571 |
| Sable form | freeze-dried powder | freeze-dried powder |

## Structure

**ARA-290 (cibinetide)** is an 11-residue linear peptide (pGlu-EQLERALNSS) modelled on helix B of erythropoietin. PubChem CID 91810664 lists the formula C51H84N16O21 and a computed molecular weight of 1257.3 g/mol (https://pubchem.ncbi.nlm.nih.gov/compound/91810664).

**Thymosin alpha-1 (thymalfasin)** is a 28-residue N-terminally acetylated peptide, originally isolated from thymus tissue. PubChem CID 16130571 lists the formula C129H215N33O55 and a computed molecular weight of 3108.3 g/mol (https://pubchem.ncbi.nlm.nih.gov/compound/16130571).

Both are peptides, so the meaningful structural differences are sequence, length and modifications rather than chemical category. Differences in residue count, terminal capping (acetylation or amidation), non-natural amino acids and lipid side chains all change molecular weight, solubility and how a compound behaves in an assay. Matching like with like at the structural level is the first step before any comparison of experimental results.

## Molecular weight in context

On PubChem's computed figures, ARA-290 (cibinetide) is a mid-sized peptide (1,000 to 3,000 g/mol) and Thymosin alpha-1 (thymalfasin) is a large peptide (over 3,000 g/mol). The difference is 1,851.0 g/mol.

Molecular weight matters in practice for three reasons. First, one milligram of a lighter compound contains more molecules than one milligram of a heavier one, so equal milligram amounts are not equal molar amounts. Second, the expected mass is what identity testing checks against: mass spectrometry on a certificate of analysis should report a value consistent with the formula. Third, salt forms (for example acetate or TFA counter-ions) and metal complexes add mass that a free-base figure does not show, so a certificate may legitimately quote a slightly different value from a database entry.

## Class and research context

**ARA-290 (cibinetide):** studied as a ligand of the innate repair receptor (EPOR/CD131 heteromer) without the haematopoietic activity of erythropoietin.

**Thymosin alpha-1 (thymalfasin):** studied in immunology research; also the active substance of a licensed medicine in some countries (Sable does not sell that medicine).

These descriptions summarise how each compound is characterised in the published literature and in chemical databases. They are not claims about effects in people, and Sable gives no administration or medical-use information for either compound. Readers who need mechanism detail should go to the primary sources and the PubChem literature sections linked below.

## How to compare them fairly

-   Compare identity first: formula, sequence and expected mass, then purity.
-   Compare amounts only at the same milligram size, remembering that equal milligrams are not equal moles.
-   Ask for the certificate of analysis for the specific batch. At Sable, every vial is released at ≥99% purity by HPLC with identity checked against the expected mass, and certificates are available for every lot.
-   Treat a search pairing as a navigation habit, not as evidence that two compounds do the same thing.

## Sable listings

Vial sizes as listed on 2026-10-10. Each product page carries the current catalogue details.

**ARA-290 (cibinetide)** (compound guide: https://www.sablepeptides.co.uk/ara-290-uk): - ARA-290 5 mg: https://www.sablepeptides.co.uk/product/ara-290-5mg - ARA-290 16 mg: https://www.sablepeptides.co.uk/product/ara-290-16mg

**Thymosin alpha-1 (thymalfasin)** (compound guide: https://www.sablepeptides.co.uk/thymosin-alpha-1-uk): - Thymosin alpha-1 5 mg: https://www.sablepeptides.co.uk/product/thymosin-alpha-1-5mg - Thymosin alpha-1 10 mg: https://www.sablepeptides.co.uk/product/thymosin-alpha-1-10mg

Peptide vials contain freeze-dried powder only; bacteriostatic water is listed separately. Research use only. Not a medicine. Not for human or veterinary use.

## Sources

-   PubChem, ARA-290 (cibinetide): https://pubchem.ncbi.nlm.nih.gov/compound/91810664
-   PubChem, Thymosin alpha-1 (thymalfasin): https://pubchem.ncbi.nlm.nih.gov/compound/16130571
-   Sable price index and methodology: https://www.sablepeptides.co.uk/pricing/methodology
-   Sable quality and certificate requests: https://www.sablepeptides.co.uk/quality

### Comparison questions

#### What is the difference between ARA-290 (cibinetide) and Thymosin alpha-1 (thymalfasin)?

ARA-290 (cibinetide) and Thymosin alpha-1 (thymalfasin) are different compounds. ARA-290 (cibinetide) is an erythropoietin-derived linear peptide; Thymosin alpha-1 (thymalfasin) is a N-acetylated thymic peptide. By PubChem's computed values, Thymosin alpha-1 (thymalfasin) (3108.3 g/mol) is about 2.5 times the mass of ARA-290 (cibinetide) (1257.3 g/mol). Sable lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.

#### What are the molecular weights of ARA-290 (cibinetide) and Thymosin alpha-1 (thymalfasin)?

ARA-290 (cibinetide): 1257.3 g/mol (PubChem CID 91810664); Thymosin alpha-1 (thymalfasin): 3108.3 g/mol (PubChem CID 16130571).

#### Are these sold for use in people?

No. Both are laboratory research material only: not medicines, and not for use in people or animals. No administration or medical-use information is provided.

ARA-290 and Thymosin alpha-1 are different research compounds, compared here by vial sizes, price per mg and published identifiers. Sable Peptides sells ARA-290 from £25.99 and Thymosin alpha-1 from £18.95. Every lot has an HPLC and mass-spectrometry Certificate of Analysis, emailed within 2 hours of a request.

Updated 2026-11-09
